CD8A and neoplasm: Except for delivering cytotoxic molecules to targets, in patients with melanoma, the ERK and NF-κB pathways are activated by CD8+ T cell-derived exosomes, resulting in the expression of matrix metalloproteinase (MMP) 9 and tumor cells becoming invasive in vitro.